| country & survey date |
survey reports and other material |
Armenia, Oct 2001
contact details
| brief survey notes
|
Bolivia, Oct 2008
contact details
| survey report (Spanish)
|
Brazil, Rio de Janeiro State, Oct 2001
contact details
| brief survey notes
|
Cameroon, May 2002
contact details
| brief survey notes
|
Chad, May 2004
contact details
| brief survey notes
survey report
pharmaceutical sector profile
summary survey report (in French only)
|
China, Shandong Province, Nov 2004
contact details
| survey report
presentation
summary survey report
|
China, Shanghai, Sep 2006
contact details
| survey report
summary survey report
|
Colombia, Oct 2008
contact details
| survey report (Spanish)
|
Congo, Jun 2007
contact details
| survey report (French)
|
Ecuador, Oct 2008
contact details
| survey report (Spanish)
|
El Salvador, Nov 2006
contact details
| addendum
survey report
|
Ethiopia, Sep 2004
contact details
| summary survey report
survey report
|
Fiji, Sep 2004
contact details
| brief survey notes
survey report
|
Ghana, May 2002
contact details
| brief survey notes
|
Ghana, Oct 2004
contact details
| survey report
summary survey report
|
India, Chennai, Oct 2004
contact details
| |
India, Haryana, Oct 2004
contact details
| |
India, Karnataka, Nov 2004
contact details
| |
India, Maharashtra (12 districts), Oct 2004
contact details
| |
India, Maharashtra (4 regions), Jan 2005
contact details
| survey report
|
India, Rajasthan, Apr 2003
contact details
| brief survey notes
survey report
|
India, West Bengal, Dec 2004
contact details
| survey report
|
Indonesia, Aug 2004
contact details
| survey report
presentation
survey summary report
|
Iran, Dec 2007
contact details
| summary survey report (available soon)
|
Jordan, May 2004
contact details
| survey report
summary report
|
Jordan, Aug 2009
contact details
| survey in progress
|
Kazakhstan, Nov 2004
contact details
| survey report
|
Kenya, Nov 2001
contact details
| brief survey notes
|
Kenya, Nov 2004
contact details
| survey report
addendum
national pharmaceutical sector form
summary survey report
|
Kuwait, Jun 2004
contact details
| survey report
presentation
addendum
summary survey report
|
Kyrgyzstan, Feb 2005
contact details
| survey report
presentation (English)
presentation (Russian)
survey summary report (English)
survey summary report (Russian)
|
Lebanon, Feb 2004
contact details
| brief survey notes
survey report
presentation
|
Malawi, Sep 2008
contact details
| survey in progress
|
Malaysia, Oct 2004
contact details
| survey report
presentation
|
Mali, Mar 2004
contact details
| pharmaceutical sector profile
summary survey report (in French only)
survey report
Formulaire du Secteur Pharmaceutique National
|
Mauritius, Aug 2008
contact details
| survey in progress
|
Mongolia, Nov 2004
contact details
| pharmaceutical sector profile
survey report
|
Morocco, Apr 2004
contact details
| survey report
survey summary report
|
Nicaragua, Oct 2008
contact details
| survey report
|
Nigeria, Sep 2004
contact details
| survey report
|
Oman, Oct 2007
contact details
| survey report
|
Pakistan, Jul 2004
contact details
| survey report
summary survey report
|
Peru, May 2002
contact details
| brief survey notes
|
Peru, Sep 2005
contact details
| survey report
|
Philippines, Jun 2002
contact details
| brief survey notes
|
Philippines, Feb 2005
contact details
| survey report
summary survey report
|
Philippines – Price components, Jul 2008
contact details
| survey report
survey summary report
|
Philippines – Public sector procurement, Jul 2008
contact details
| survey report
survey summary report
|
Rwanda, Jul 2009
contact details
| survey in progress
|
Sao Tome and Principe, Jun 2008
contact details
| survey report (Portugese)
|
South Africa, Gauteng Province, Nov 2004
contact details
| survey report
addendum
|
South Africa, KwaZulu Natal State, Sep 2001
contact details
| brief survey notes
|
Sri Lanka, Oct 2001
contact details
| brief survey notes
|
Sudan, Jun 2005
contact details
| survey report (available soon)
|
Syria, Dec 2003
contact details
| survey report
presentation
summary survey report
|
Tajikistan, Feb 2005
contact details
| survey report
|
Tanzania, Sep 2004
contact details
| survey report
summary survey report
|
Thailand, Oct 2006
contact details
| survey summary report
survey report
journal article
|
Tunisia, Mar 2004
contact details
| survey report English
survey report French
|
Uganda, Apr 2004
contact details
| summary survey report
survey report
|
Ukraine - Essential Medicines, Sep 2007
contact details
| summary survey report
|
Ukraine - Palliative Care Medicines, Sep 2007
contact details
| summary survey report
|
United Arab Emirates, Dec 2006
contact details
| survey summary report
|
Viet Nam, Nov 2005
contact details
| journal article
|
Yemen, Jul 2006
contact details
| survey report
summary survey report
|
| Zambia, Aug 2008 | survey in progress
|
| If you have questions about one of these surveys, please contact the survey manager (see
the 'contact details' page for each survey).
|
Important information about survey data
Public sector procurement prices are prices that governments or other purchasers pay to procure medicines for use in the public sector. In some countries, medicines are only procured by the government (often via a central tender). In others, various agencies also procure for the public sector e.g. in Lebanon medicines are procured by the government and UNICEF. In some countries, public sector facilities obtain medicines via various stores e.g. in Uganda medicines are obtained from the National Medical Store and the Joint Medical Store. In other countries, medicines are procured both from a central store and local purchasing, or solely by local purchasing.
In the India surveys, procurement prices represent the prices paid by the public sector facilities. In some states there were no distribution costs (so the price paid by the facility was the tender price) but in others variable components costs applied such as handling charges and/or taxes. Footnotes have been included where HAI was advised that distribution costs are included in the procurement price.
WHO and HAI recommend analysing all the price component costs (mark-ups, taxes etc) as a medicine goes through the distribution chain from manufacturer to patient. As it is often very difficult to obtain the manufacturer’s selling price for a medicine, WHO and HAI recommend you work back from the patient price, assessing the type and amount of each component such as VAT, pharmacy mark-up, wholesale mark-up, importer mar-ups, import tax etc. From this you can assess the manufacturers selling price (for locally produced products) or the price of imported products. Please be aware that survey managers may have experienced difficulties identifying whether these products are sold as CIF, FOB, ex-factory etc. Comparisons should be made with caution.
|
